The in vivo Behavioral Assessment Core will provide both service-oriented behavioral phenotyping and research staff training to investigators using rodents. One of the major goals of the Core will be the development and operation of a consolidated facility in which transgenic mice can reliably and consistently be tested using the most-accepted battery of behavioral tests, the SHIRPA (Rogers et al., 1997), along with expanded maze testing. The battery will include a primary behavioral screen, sensory and motor tests (including rotorod, spontaneous locomotor activity, walking coordination, etc.), an open field test for emotionality and exploratory activity and cognitive testing (including elevated plus-maze, Morris water maze, holeboard maze and eight-arm radial maze tasks). Most of the tasks will be automated, thereby greatly decreasing any potential investigator bias from the results. In most instances, the Initial phenotyping of a transgenic line will be carried out by the staff of the Core, who will be blinded to the genetic background of the mice. In those instances in which the investigator is interested in further characterizing the detailed behavior of a line of mice or a treatment, the staff and Director will train personnel from the investigator's lab to conduct more extensive studies, using the equipment of the Core. The Core will provide a similar assessment of rat behavior in apparatuses designed for these animals. For both rats and mice, the Core will, when deemed appropriate, test the animals using more sophisticated cognitive tasks for characterizing small differences between groups. For all animals tested, the Core will provide initial statistical analyses of resulting data in the reports to the investigators. The Core will also afford research personnel from the participating laboratories the opportunity to train in the use of these behavioral testing methods. This will particularly benefit investigators who require extended testing beyond the complexity offered in the standardized protocols of the Core. The Core will also assist investigators in the development of tools that are needed by them for a more detailed assessment of specific behaviors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Center Core Grants (P30)
Project #
5P30NS047466-03
Application #
7436292
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
3
Fiscal Year
2007
Total Cost
$142,819
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Arrant, Andrew E; Nicholson, Alexandra M; Zhou, Xiaolai et al. (2018) Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency. Mol Neurodegener 13:32
Bohannon, Andrew S; Hablitz, John J (2018) Optogenetic dissection of roles of specific cortical interneuron subtypes in GABAergic network synchronization. J Physiol 596:901-919
Arrant, Andrew E; Onyilo, Vincent C; Unger, Daniel E et al. (2018) Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis. J Neurosci 38:2341-2358
Wadsworth, Heather M; Maximo, Jose O; Donnelly, Rebecca J et al. (2018) Action simulation and mirroring in children with autism spectrum disorders. Behav Brain Res 341:1-8
McMeekin, Laura J; Li, Ye; Fox, Stephanie N et al. (2018) Cell-Specific Deletion of PGC-1? from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment. J Neurosci 38:3273-3286
Harms, Ashley S; Thome, Aaron D; Yan, Zhaoqi et al. (2018) Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol 300:179-187
Wang, Bing; Underwood, Rachel; Kamath, Anjali et al. (2018) 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic ?-Synuclein. J Neurosci 38:8211-8232
Rangarajan, Sunad; Bone, Nathaniel B; Zmijewska, Anna A et al. (2018) Metformin reverses established lung fibrosis in a bleomycin model. Nat Med 24:1121-1127
Arrant, Andrew E; Filiano, Anthony J; Patel, Aashka R et al. (2018) Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice. Neurobiol Dis 124:152-162
Ramani, Manimaran; Kumar, Ranjit; Halloran, Brian et al. (2018) Supraphysiological Levels of Oxygen Exposure During the Neonatal Period Impairs Signaling Pathways Required for Learning and Memory. Sci Rep 8:9914

Showing the most recent 10 out of 207 publications